Prostate cancer in senior adults: over- or undertreated? Wien Med Wochenschr 2009; 159(21-22):521-528.Berger I, Bohmer F, Ponholzer A, Madersbacher S (2009) Prostate cancer in senior adults: over- or undertreated? Wien Med Wochenschr 159:521–528...
One of the reasons why it has taken this decision is that it believes some men would be over-treated. But, in the US, all men are offered routine PSA screening at 50 - they are offered the test at 40 if they show symptoms or have a family history of prostate cancer, or belong t...
However screening of prostate cancer in all men regardless of symptoms must wait for a larger study looking at long term survival benefit, cost-effectiveness of screening, and lastly, quality of life of patients on a screening program. 展开 关键词: Prostate cancer Prevalence PSA IPSS ...
Int J Radiat Oncol Biol Phys 59: 1424–1431 Bone complications in prostate cancer Androgen deprivation therapy (ADT), often using luteinizing hormone-releasing hormone (LHRH) agonists, is common in the treatment of progres- sive prostate carcinoma. The resulting therapeu- tic hypogonadism is ...
Change in Prostate Cancer Grade Over Time in Men Followed Expectantly for Stage \\{T1c\\} Disease: Sheridan TB, Carter HB, Wang W, et al (The Johns Hopkins... Change in prostate cancer grade over time in men followed expectantly for stage T1c disease. J Urol 2008;179:901-4.Sheridan...
MYC is an important driver oncogene for prostate cancer (PrCa) [1], the second most frequent cancer in men worldwide [2]. Amplification of MYC locus, one of the most common chromosome alternation in PrCa, occurs in over 8% of primary PrCa and 20% of metastatic PrCa [3,4,5,6,7,8]...
Only 20 per cent of men over 50 would opt for surgical treatment if faced with localised prostate cancer, according to a study by Plymouth University. Dr Belen Lopez-Perez and Professor Yaniv Hanoch, from the University's School of Psychology, surveyed 279 men over 50 who had not had the ...
Afterskin cancer, prostatecanceris the most commoncancerin men and in people assigned male a birth. About 1 in 8 will be diagnosed with prostate cancer in their lifetime. And these are just the ones who are diagnosed. Among very elderly men who die of other causes, a surprising two-third...
Although mortality fromprostate cancerhas declined over the past few years, demographic trends, such as the general aging of the population, suggest thatprostate cancerwill remain one of the most common health threats for men in the developed world. Widespread implementationof prostate cancer screening...
Treatment of these men results in harms and provides them with no benefit. This is known as overdiagnosis, and follow-up of large randomized trials suggests that 20% to 50% of men diagnosed with prostate cancer through screening may be overdiagnosed.3 Overdiagnosis rates would be expected to ...